| Similar Articles |
|---|
 |
Chemistry World
October 5, 2015
Matthew Gunther |
Antiparasitic drugs derived from natural products take 2015 medicine Nobel The 2015 Nobel prize in physiology or medicine has been split between three researchers for unearthing two naturally-occurring antimicrobial products that can fight parasitic diseases such as malaria and river blindness.   |
Chemistry World
July 2010 |
Supporting science The Wellcome Trust is one of the largest science funding bodies in the world. Sir Mark Walport, the trust's director, tells Phillip Broadwith how it spends its money |
Chemistry World
March 4, 2015
Philip Ball |
Program ready to weed out tough drug leads A method for reliably predicting how well a candidate drug molecule will bind to its target receptor would allow libraries of molecules to be screened on the computer, without having to synthesize them all. |
Chemistry World
October 9, 2013
Emma Stoye |
Computational chemists take Nobel prize The 2013 Nobel prize in chemistry has been awarded to Martin Karplus of Harvard University, US, Michael Levitt of Stanford University, US, and Arieh Warshel of the University of Southern California, US, for "the development of multi-scale models for complex chemical systems." |
Technology Research News
March 23, 2005 |
Nanowires track molecular activity Researchers from Harvard University have found a way to use transistors made from silicon nanowires to gain information about how small molecules bind to proteins. |
Pharmaceutical Executive
September 1, 2005
Parker & Amar |
Building Blockbusters The most lucrative new drugs are often less glamorous than first-in-class new molecular entities. And they are much less risky. |
HHMI Bulletin
Winter 2013
Sarah Goforth |
Rational Exuberance Trained as a cardiologist, Robert Lefkowitz is the first to admit that his 39-year research career has been driven by more than a desire to treat coronary disease. He has always had an unshakeable urge to figure things out. |
Chemistry World
October 7, 2015 |
Live blog: Unravelling DNA repair mechanisms takes chemistry Nobel Our live blog explains the vital statistics of the Nobel chemistry prize and the countdown to the award announcement. |
Chemistry World
July 11, 2008
Manisha Lalloo |
Side-effects study opens up new drug leads Existing drugs could be used to treat a broader range of diseases, according to scientists in Germany and Denmark, who have predicted drug targets by using side-effects data on medication labels. |
Chemistry World
December 2007
Derek Lowe |
Column: In the Pipeline The challenge of biologics. |
BusinessWeek
September 5, 2005 |
Putting the FDA Out Front Deputy Commissioner Dr. Janet Woodcock explains how the agency has led the drive for personalized medicine. |
Chemistry World
December 2008 |
Column: In the pipeline I've worked on two drug discovery efforts (one right after the other, as fate would have it) whose final compounds differed by essentially one methyl group from the starting points of each project. |
Bio-IT World
April 15, 2003
Mark D. Uehling |
Target Elimination Industry and FDA scientists turn to databases, applications software, and laboratory chips to move the safest, most effective molecules into clinical trials. |
Chemistry World
January 2011 |
My hero: The greatest influences of chemistry Nobel laureates Harry Kroto was one of three recipients to share the 1996 Nobel prize in chemistry for the discovery of fullerenes (buckyballs) and he offers his opinion of Sir John (Kappa) Cornforth. |
HBS Working Knowledge
November 3, 2014
Carmen Nobel |
Brand Lessons From the Nobel Prize What makes the Nobel Prize so coveted? Stephen Greyser and Mats Urde discuss the first field-based study exploring the prize from a brand and reputation perspective. |
Bio-IT World
October 2005
Lorna Jack |
Biotech Beckons in Bonny Scotland U.S. biotechs are commonly attracted to Scotland because of the excellent opportunities available for collaboration with biomedical innovators. |
Chemistry World
November 2009
Bibiana Campos-Seijo |
Editorial: Ringing in the Nobels This year the chemistry prize seems to have once again caused a bit of a commotion. The criticism? Well, some in the scientific community have suggested that the research had too strong a biological focus. |
Chemistry World
November 2, 2015
Philip Robinson |
A Nobel purpose The Nobel categories are fields that support Nobel's humanitarian goals, and looking at this year's awards, there is a notable humanitarian, even humanist, flavor. |
Bio-IT World
April 2007
Malorye Allison |
Biomarkers versus Blockbusters Are companies really changing their strategies and using biomarkers to target smaller, better defined patient sets with their new drugs? Or is the vast majority of pharma biomarker studies just aimed at culling bad drugs from their pipelines? |
The Motley Fool
August 15, 2007
Mary Dalrymple |
Drug Costs Giving You a Headache? If you want to cut your prescription drug costs, you can do more than just switch to generic brands. Shop around and ask questions. It's your health, and it's your money. |
Chemistry World
November 2010 |
Column: In the Pipeline Should drug companies focus on big markets and the blockbuster dream? |
The Motley Fool
November 22, 2005
Brian Gorman |
Saying No to Drugs Britain's policy of restricting drug access based on cost-benefit analyses should be on the radar screen of pharmaceutical investors. |
Reason
April 2001
Ronald Bailey |
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? |
